Primary Extranodal Non-Hodgkin's Lymphoma in Adults: Clinicopathological and Survival Characteristics
- 1 January 1996
- journal article
- research article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 21 (1-2) , 131-136
- https://doi.org/10.3109/10428199609067590
Abstract
Among 318 cases of non-Hodgkin's lymphoma (NHL) treated in our unit, 145 (45.6%) had primary extranodal NHL (PE-NHL). The stomach was the most common site (42.1%), followed by the PE-NHL of the head and neck region. Histologically aggressive histologies (65.5% intermediate and 20.7% high grade) predominated. 89.6% of the cases were localized (stage IE, 51% and stage II, 38.6%) but 28% had B symptoms. CR was achieved in 82.1% of the cases. 5-years disease free survival and overall survival were both 65%. Factors that influence prognosis were stage and high grade histology. Among various primary sites the Waldeyer's ring, small intestine and testes had the worse prognosis. Compared to nodal NHL, the PE-NHL were more frequently localized, belonged more often to aggressive histologies and had more often distal extranodal relapses. CR rates and disease free and overall survival were significantly better for PE-NHL. The survival rates, however, listed according to stage and histology for nodal and PE-NHL were not different. We conclude that although PE-NHL differed from nodal NHL in several respects, prognosis is mainly a factor of stage and histology rather than of the primary localization per se.Keywords
This publication has 58 references indexed in Scilit:
- The role of interleukin‐1 and tumour necrosis factor‐α in human multiple myelomaBritish Journal of Haematology, 1990
- Autocrine Growth by Two Cytokines, Interleukin-6 and Tumor Necrosis Factor Alpha, in the Myeloma Cell Line KHM-1AActa Haematologica, 1990
- Immunophenotypic Analysis of Lymphocytes and Myeloma Cells in Patients with Multiple MyelomaActa Haematologica, 1990
- Detection of monoclonal B lymphocytes in bone marrow and peripheral blood of multiple myeloma patients by immunoglobulin gene rearrangement studiesBritish Journal of Haematology, 1989
- Circulating monoclonal B lymphocytes in multiple myelomaBritish Journal of Haematology, 1989
- Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomasNature, 1988
- Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma.Journal of Clinical Investigation, 1985
- Monoclonal B Lymphocytes in Multiple MyelomaScandinavian Journal of Immunology, 1980
- Studies on the clonal origin of multiple myeloma. Use of individually specific (idiotype) antibodies to trace the oncogenic event to its earliest point of expression in B-cell differentiation.The Journal of Experimental Medicine, 1979
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975